Literature DB >> 18396204

Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum.

Richard E Royal1, James F Pingpank.   

Abstract

Peritoneal carcinomatosis (the implantation of tumor cells throughout the peritoneal cavity) occurs in as many as 50% of patients with colorectal cancer and in up to 25% is the only site of recurrence. There is increasing evidence that aggressive debulking of peritoneal only disease followed by intraperitoneal chemotherapy can have significant impact on the patient's quality and sometimes quantity of life. This chapter will provide an overview of the biologic basis of pathogenesis and the treatment of peritoneal metastases from colorectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18396204     DOI: 10.1053/j.seminoncol.2007.12.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Tiffany Sin Hui Bong; Grace Hwei Ching Tan; Claramae Chia; Khee Chee Soo; Melissa Ching Ching Teo
Journal:  Int J Clin Oncol       Date:  2017-01-30       Impact factor: 3.402

2.  Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer.

Authors:  Gregory A Otterson; Miguel A Villalona-Calero; William Hicks; Xueliang Pan; John A Ellerton; Scott N Gettinger; John R Murren
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

3.  Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations.

Authors:  Ning Miao; James F Pingpank; H Richard Alexander; Richard Royal; Seth M Steinberg; Martha M Quezado; Tatiana Beresnev; Zenaide M N Quezado
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

4.  Evaluation of intraperitoneal lavage cytology before colorectal cancer resection.

Authors:  Shoichi Fujii; Hiroshi Shimada; Shigeru Yamagishi; Mitsuyoshi Ota; Chikara Kunisaki; Hideyuki Ike; Yasushi Ichikawa
Journal:  Int J Colorectal Dis       Date:  2009-05-28       Impact factor: 2.571

5.  TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.

Authors:  M F Ziauddin; Z S Guo; M E O'Malley; F Austin; P J Popovic; M A Kavanagh; J Li; M Sathaiah; P Thirunavukarasu; B Fang; Y J Lee; D L Bartlett
Journal:  Gene Ther       Date:  2010-02-25       Impact factor: 5.250

6.  Case Report of Multimodality Imaging in Omental Cake: Plain Radiograph, Computed Tomography, and Ultrasonography: A Care-Compliant Article.

Authors:  Yu-Hsiang Juan; Yun-Chung Cheung; Koon-Kwan Ng; Shu-Hang Ng; Jen-Seng Huang; Liang-Che Chang; Yu-Ching Lin
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.